The Impact of Metabolic Syndrome and Obesity on the Evolution of Diastolic Dysfunction in Apparently Healthy Patients Suffering from Post-COVID-19 Syndrome.
COVID-19
diastolic dysfunction
inflammation
metabolic syndrome
obesity
post-COVID-19 syndrome
transthoracic echocardiography
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
27 Jun 2022
27 Jun 2022
Historique:
received:
31
05
2022
revised:
21
06
2022
accepted:
24
06
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
(1) Background: Coronavirus disease 2019 (COVID-19) has a worse prognosis in individuals with obesity and metabolic syndrome (MS), who often develop cardiovascular complications that last throughout recovery. (2) Methods: This study aimed to analyze the evolution of diastolic dysfunction (DD), assessed by transthoracic echocardiography (TTE), in 203 individuals with and without obesity and/or MS diagnosed with post-COVID-19 syndrome. (3) Results: DD was frequently diagnosed in patients with MS and obesity, but also in those without obesity (62.71% and 56.6%, respectively), in comparison to 21.97% of subjects without MS (
Identifiants
pubmed: 35884823
pii: biomedicines10071519
doi: 10.3390/biomedicines10071519
pmc: PMC9312435
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Clin Med. 2021 Jun 06;10(11):
pubmed: 34204032
JAMA Cardiol. 2020 Nov 01;5(11):1265-1273
pubmed: 32730619
Eur Respir J. 2020 Jul 2;56(1):
pubmed: 32398306
BMJ Open Diabetes Res Care. 2018 Aug 13;6(1):e000484
pubmed: 30116540
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Obesity (Silver Spring). 2020 Jul;28(7):1200-1204
pubmed: 32352637
Circulation. 2020 Jul 28;142(4):342-353
pubmed: 32469253
Cell Metab. 2021 Nov 2;33(11):2174-2188.e5
pubmed: 34599884
Lancet Reg Health Eur. 2021 Jul;6:100122
pubmed: 34027514
Int J Obes (Lond). 2021 Jun;45(6):1163-1169
pubmed: 33727631
Lancet Diabetes Endocrinol. 2021 Nov;9(11):786-798
pubmed: 34619105
Circulation. 2020 Sep 15;142(11):1120-1122
pubmed: 32673505
JAMA. 2020 Oct 20;324(15):1499-1500
pubmed: 33001179
Obes Res Clin Pract. 2020 Sep - Oct;14(5):398-403
pubmed: 32736969
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
Circ Res. 2021 Apr 16;128(8):1214-1236
pubmed: 33856918
Expert Rev Anti Infect Ther. 2021 Sep;19(9):1083-1092
pubmed: 33618607
Clin Infect Dis. 2020 Jul 28;71(15):896-897
pubmed: 32271368
Int J Obes (Lond). 2018 Mar;42(3):441-447
pubmed: 28974742
Eur Heart J. 2020 May 14;41(19):1798-1800
pubmed: 32186331
Future Cardiol. 2021 Jul;17(4):655-661
pubmed: 33034203
Nat Metab. 2021 Mar;3(3):289-292
pubmed: 33633407
Clin Rev Allergy Immunol. 2021 Feb 20;:
pubmed: 33609255
Int J Sports Med. 2021 Mar;42(3):199-214
pubmed: 33075830
Heart. 2020 Sep;106(17):1324-1331
pubmed: 32675217
Metabolism. 2021 Jun;119:154769
pubmed: 33775648
J Thromb Thrombolysis. 2020 Oct;50(3):512-524
pubmed: 32880795
J Pers Med. 2022 Jan 04;12(1):
pubmed: 35055360
Clin Infect Dis. 2022 Apr 9;74(7):1191-1198
pubmed: 34223884
Int J Cardiovasc Imaging. 2021 Jan;37(1):135-144
pubmed: 32803484
Acta Pharmacol Sin. 2021 Oct;42(10):1567-1574
pubmed: 33510459
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
J Am Soc Echocardiogr. 2009 Feb;22(2):107-33
pubmed: 19187853
Eur Heart J. 2022 Mar 14;43(11):1157-1172
pubmed: 35176758
Nat Commun. 2022 Jun 28;13(1):3528
pubmed: 35764621
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
JAMA Cardiol. 2020 Jul 1;5(7):831-840
pubmed: 32219363
Echocardiography. 2018 Aug;35(8):1124-1131
pubmed: 29664200
Iran J Med Sci. 2021 Nov;46(6):428-436
pubmed: 34840383
J Pers Med. 2021 Mar 22;11(3):
pubmed: 33809873
JAMA. 2020 Nov 3;324(17):1723-1724
pubmed: 33031513
BMJ Open. 2022 Apr 27;12(4):e059281
pubmed: 35477881